Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia
Posaconazole is a commonly used medication for antifungal prophylaxis in patients with high-risk acute leukemia, such as acute myeloid leukemia. Despite clinical data that show that posaconazole is superior to other antifungal prophylaxis medications, posaconazole is known to have many side effects...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-02-01
|
| Series: | Journal of Investigative Medicine High Impact Case Reports |
| Online Access: | https://doi.org/10.1177/2324709617690747 |
| _version_ | 1811204147148488704 |
|---|---|
| author | Mayur D. Mody MD Deepak Ravindranathan MD Harpaul S. Gill MD Vamsi K. Kota MD |
| author_facet | Mayur D. Mody MD Deepak Ravindranathan MD Harpaul S. Gill MD Vamsi K. Kota MD |
| author_sort | Mayur D. Mody MD |
| collection | DOAJ |
| description | Posaconazole is a commonly used medication for antifungal prophylaxis in patients with high-risk acute leukemia, such as acute myeloid leukemia. Despite clinical data that show that posaconazole is superior to other antifungal prophylaxis medications, posaconazole is known to have many side effects and drug-drug interactions. We present a patient who developed rhabdomyolysis after being started on posaconazole for prophylaxis in the setting of relapsed acute myeloid leukemia. |
| first_indexed | 2024-04-12T03:06:33Z |
| format | Article |
| id | doaj.art-ab5600cd5ce3499c92034282a3f1b38c |
| institution | Directory Open Access Journal |
| issn | 2324-7096 |
| language | English |
| last_indexed | 2024-04-12T03:06:33Z |
| publishDate | 2017-02-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Journal of Investigative Medicine High Impact Case Reports |
| spelling | doaj.art-ab5600cd5ce3499c92034282a3f1b38c2022-12-22T03:50:29ZengSAGE PublishingJournal of Investigative Medicine High Impact Case Reports2324-70962017-02-01510.1177/232470961769074710.1177_2324709617690747Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid LeukemiaMayur D. Mody MD0Deepak Ravindranathan MD1Harpaul S. Gill MD2Vamsi K. Kota MD3Emory University, Atlanta, GA, USAEmory University, Atlanta, GA, USAEmory University, Atlanta, GA, USAEmory University, Atlanta, GA, USAPosaconazole is a commonly used medication for antifungal prophylaxis in patients with high-risk acute leukemia, such as acute myeloid leukemia. Despite clinical data that show that posaconazole is superior to other antifungal prophylaxis medications, posaconazole is known to have many side effects and drug-drug interactions. We present a patient who developed rhabdomyolysis after being started on posaconazole for prophylaxis in the setting of relapsed acute myeloid leukemia.https://doi.org/10.1177/2324709617690747 |
| spellingShingle | Mayur D. Mody MD Deepak Ravindranathan MD Harpaul S. Gill MD Vamsi K. Kota MD Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia Journal of Investigative Medicine High Impact Case Reports |
| title | Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia |
| title_full | Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia |
| title_fullStr | Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia |
| title_full_unstemmed | Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia |
| title_short | Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia |
| title_sort | rhabdomyolysis following initiation of posaconazole use for antifungal prophylaxis in a patient with relapsed acute myeloid leukemia |
| url | https://doi.org/10.1177/2324709617690747 |
| work_keys_str_mv | AT mayurdmodymd rhabdomyolysisfollowinginitiationofposaconazoleuseforantifungalprophylaxisinapatientwithrelapsedacutemyeloidleukemia AT deepakravindranathanmd rhabdomyolysisfollowinginitiationofposaconazoleuseforantifungalprophylaxisinapatientwithrelapsedacutemyeloidleukemia AT harpaulsgillmd rhabdomyolysisfollowinginitiationofposaconazoleuseforantifungalprophylaxisinapatientwithrelapsedacutemyeloidleukemia AT vamsikkotamd rhabdomyolysisfollowinginitiationofposaconazoleuseforantifungalprophylaxisinapatientwithrelapsedacutemyeloidleukemia |